key: cord-0990589-qa3146ll
authors: Adachi, Eisuke; Saito, Makoto; Nagai, Hiroyuki; Ikeuchi, Kazuhiko; Koga, Michiko; Tsutsumi, Takeya; Yotsuyanagi, Hiroshi
title: Transient depletion of T cells during COVID‐19 and seasonal influenza in people living with HIV
date: 2022-01-11
journal: J Med Virol
DOI: 10.1002/jmv.27543
sha: 6f9359d94fe06ccaa6114631f72401675b2c7ccd
doc_id: 990589
cord_uid: qa3146ll

The cellular immune deficiency seen in people living with HIV (PLWH) is of potential concern as dysfunctional immune responses contribute to disease progression and dysregulated T cell responses can result in immunopathology. This article is protected by copyright. All rights reserved.

To the editor,

The cellular immune deficiency seen in people living with HIV (PLWH) is of potential concern as dysfunctional immune responses contribute to disease progression and dysregulated T cell responses can result in immunopathology. 1, 2 Transient decrease in lymphocytes during COVID-19 is well known and a preexisting T cell depletion induced by HIV may cause deleterious clinical consequences. 3 Additionally, seasonal influenza has been compared with COVID-19 given the common features shared by these viruses, such as fever and respiratory symptoms that range from mild forms to severe pneumonia, whereas these two viruses differ in their receptors for infection and the duration and incubation period of the disease they cause. T cell responses could affect both the initial nonspecific innate immune response and the following antigen-specific adaptive immunity, which is mediated by humoral immunity and T cells including CD8+, CD4+ and regulatory T cells. 4 In this study, we investigated the changes in To examine the transient changes in the T cell count before and after infection and to exclude changes due to other factors, we included only PLWH who had been on effective antiretroviral therapy for at least 1 year and who had the results of T cell subset at all of the three time points above. We used the repeated measures analysis of variance to compare the three time points and the paired t-test were used to evaluate the difference between cell counts before symptom onset and during illness. Statistical significance was defined as twosided p values < 0.05.

As shown in Table 1 , there were significant changes in the transition of T cell counts in both influenza infection and COVID-19.

A total of 17 COVID-19 patients was eligible; all were inpatients, and seven patients were with moderate or higher disease. Sixteen patients were male the median age was 53 years (range: 26-68). The mean CD4+ cell count was 659 cells/μl, 436 cells/μl, and 686 cells/μl (before onset, during infection and after recovery, respectively) (before onset vs. during infection: p = 0.0001, Figure 1A ), CD8+ T cell count was 805 cells/μl, 539 cells/μl, and 831 cells/μl (before onset vs. during infection: p = 0.0026, Figure 1B) , and CD4+/CD8+ ratio was 0.94, 0.870, and 0.96 (before onset vs. during infection: Figure 1C ). The mean lymphocyte count was 2148 cells/μl, 1505 cells/μl, and 2066 cells/μl (before onset vs. during infection: p = 0.0003). There was no significant change in CD4+ cell, CD8+ cell, and total lymphocyte counts between those before symptom onset and after recovery.

Next, we analyzed a total of 27 Influenza infections; there were no hospitalizations, and no patients had pneumonia or encephalopathy. All patients were male, and the median age was 39.5 years Three time points were as follows, before onset: within 3 months before symptom onset, during infection: within 10 days postsymptom onset, after recovery: within 1-6 months after recovery. The paired t-test were used to evaluate the difference between cell counts before onset and during infection. *Statistical significance was defined as two-sided p < 0. 

Immunology of COVID-19: current state of the science

Viral and host factors related to the clinical outcome of COVID-19

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

Protective immunity against COVID-19: unravelling the evidences for humoral vs. cellular components

T-cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of coronavirus disease 2019

Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome